Quick Facts: Valeant Pharmaceuticals International, Inc. (NYSE:VRX), Integrated Device Technology, Inc. (NASDAQ:IDTI)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) released that it has delivered a letter to the BOD of Allergan (AGN). Allergan would not be trading anywhere close to where it is absent our offer, and our offer, even at Valeant's current stock price, represents a very substantial premium. Allergan's shares were trading at $110 at the beginning of the year, and $117 before we made our offer. Shares of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) opened at $129.37 with 334.09 million outstanding shares and hit to its highest price of $130.82 during the day and finally closed at $130.56 by scoring 1.11%. In the whole session, it traded on volume of 2.83 Million shares, which turned higher than its average volume.Integrated Device Technology, Inc. (NASDAQ:IDTI) reported that it introduced a new low-distortion, low-power radio frequency mixer, delivering RF technology that cuts distortion in LTE and TDD systems while minimizing power consumption. On the other consideration, Integrated Device Technology, Inc. (NASDAQ:IDTI) begun last trade with a price of $14.01 and throughout the trading session climbed at $14.22. The day-trade ended with a gain of 0.29% to closed at $14.04.